8:35am - 9:05am Monday, February 11

Location & Room

Orlando - Rosen Centre
Rosen Centre Executive Ballroom H
Extra Fee

The obstacles to personalized medicine include the high cost of precision cancer drugs, the challenge of getting patients fully engaged in their own care, a lack of mature, universal interoperability, and questions about the effectiveness of precision medicine interventions.

In this presentation, industry thought-leader John Halamka, MD, who co-authored the book, Realizing the Promise of Precision Medicine, will address these issues and conclude with a personal story about his wife, Kathy Halmaka, who was successfully treated for breast cancer with a personalized approach that included using the digital technologies SHRINE, i2b2, and Clinical Query 2.

Key Takeaways

·        The cost effectiveness of personalized medicine is a work in progress.
·        Carefully selected digital technology will help get patients engaged in personalized care.
·        Software suites and clinical research databases are already demonstrating the value of precision medicine.